Zevra Therapeutics, Inc. Investments, Fair Value Disclosure
Zevra Therapeutics, Inc. (ZVRA) had Investments, Fair Value Disclosure of $43.30 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:InvestmentsFairValueDisclosure · last filed 2026-08-05
- 2026-06-30: Investments, Fair Value Disclosure $43.30M.
- 2026-03-31: Investments, Fair Value Disclosure $82.60M.
- 2025-12-31: Investments, Fair Value Disclosure $176.50M.
- 2025-09-30: Investments, Fair Value Disclosure $175.90M.
| Period end | Investments, Fair Value Disclosure | Investments, Fair Value Disclosure as first filed |
|---|---|---|
| 2026-06-30 | $43.30M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $82.60M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $176.50M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $175.90M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $170.00M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $31.40M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $41.70M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $41.40M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $10.00M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $9.90M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $24.70M 10-K · filed 2025-03-12 | |
| 2023-09-30 | $39.70M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $20.70M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $34.40M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $16.90M 10-K · filed 2024-04-01 | |
| 2021-12-31 | $14.90M 10-K · filed 2023-03-07 | $15.40M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |